4.4 Article

Transcription Factor Expression in Sinonasal Neuroendocrine Neoplasms and Olfactory Neuroblastoma (ONB): Hyams' Grades 1-3 ONBs Expand the Spectrum of SATB2 and GATA3-Positive Neoplasms

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Pathology

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Overview of the 2022 WHO Classification of Head and Neck Neuroendocrine Neoplasms

Ozgur Mete et al.

Summary: This review article provides a brief overview of the new WHO classification for head and neck neuroendocrine neoplasms. It discusses the spectrum of these neoplasms, diagnostic criteria, and offers insights into the role of biomarkers and molecular immunohistochemistry in accurate diagnosis. The article emphasizes the importance of morphology and immunohistochemical findings in the classification and diagnosis of neuroendocrine neoplasms.

HEAD & NECK PATHOLOGY (2022)

Review Biochemistry & Molecular Biology

SATB2: A versatile transcriptional regulator of craniofacial and skeleton development, neurogenesis and tumorigenesis, and its applications in regenerative medicine

Xia Huang et al.

Summary: SATB2 is a transcription regulator that plays important roles in skeletal and craniofacial development, as well as in neural development and cancer progression. It holds great promise as an osteoinductive factor for improving bone defect repair.

GENES & DISEASES (2022)

Review Otorhinolaryngology

The genomics and epigenetics of olfactory neuroblastoma: A systematic review

Raman Preet Kaur et al.

Summary: Although recurrent mutations in ONB tumors are rare, recent studies have reported alterations in genes such as TP53, DMD, PIK3CA, NF1, CDKN2A, CDKN2C, CTNNB1, EGFR, APC, cKIT, cMET, PDGFRA, CDH1, FH, SMAD4, FGFR3, and IDH2. Additionally, cytogenetic studies have shown a wide variation in chromosomal aberrations among ONB tumors. Further comprehensive studies with larger cohorts are needed to validate these findings and identify potential therapeutic targets for ONB.

LARYNGOSCOPE INVESTIGATIVE OTOLARYNGOLOGY (2021)

Article Pathology

Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours

Sambit Kumar Mohanty et al.

Summary: Determining the site of origin of a metastatic neuroendocrine tumour (NET) can be challenging and has important prognostic and therapeutic implications. A panel of immunohistochemical (IHC) markers is often employed for this purpose, with SATB2 potentially playing a role in differentiating pancreatic and rectal NETs. Including SATB2 in the panel could improve specificity for pancreaticoduodenal NETs, and complement other markers in determining the site of origin in a metastatic setting.

JOURNAL OF CLINICAL PATHOLOGY (2021)

Article Multidisciplinary Sciences

Satb2 neurons in the parabrachial nucleus mediate taste perception

Brooke C. Jarvie et al.

Summary: Researchers have identified a population of neurons in the gustatory region of the parabrachial nucleus that express the transcription factor Satb2 and respond to the five basic taste modalities. Activation of these neurons enhances taste preferences, while inactivation decreases taste preferences, indicating their role in modulating taste preferences.

NATURE COMMUNICATIONS (2021)

Article Oncology

Methylation Drivers and Prognostic Implications in Sinonasal Poorly Differentiated Carcinomas

Laura Libera et al.

Summary: This study performed histopathological, immunohistochemical, and molecular analyses on PDSNCs, revealing a correlation between SWI/SNF complex and IDH2 defects and abnormal methylation levels, which were associated with a worse prognosis.

CANCERS (2021)

Article Endocrinology & Metabolism

Middle Ear Adenoma: a Neuroendocrine Tumor with Predominant L Cell Differentiation

Sylvia L. Asa et al.

Summary: This study identifies middle ear adenomas as well-differentiated epithelial neuroendocrine tumors resembling hindgut NETs, expressing specific markers and providing a valuable immunohistochemical profile for differential diagnosis. The findings also open new areas of investigation into the physiology and pathophysiology of the normal middle ear and middle ear disorders.

ENDOCRINE PATHOLOGY (2021)

Article Oncology

Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets

Chiara Romani et al.

Summary: The gene expression profile of ONB identifies patients with a poor prognosis and potential targetable pathways. The ontogenesis of ONB in basal and neural subtypes reflects different transcriptional pathways, which may lead to different therapeutic approaches. Studying altered transcriptional pathways can help tailor postoperative treatment.

CANCERS (2021)

Article Multidisciplinary Sciences

An atlas of the protein-coding genes in the human, pig, and mouse brain

Evelina Sjostedt et al.

SCIENCE (2020)

Article Clinical Neurology

DNA methylation-based reclassification of olfactory neuroblastoma

David Capper et al.

ACTA NEUROPATHOLOGICA (2018)

Article Cell Biology

Utility of GATA3 in the differential diagnosis of pheochromocytoma

Carmen M. Perrino et al.

HISTOPATHOLOGY (2017)

Article Dermatology

SATB2 is expressed in Merkel cell carcinoma

Mari Fukuhara et al.

ARCHIVES OF DERMATOLOGICAL RESEARCH (2016)

Article Pathology

A Study of Gata3 and Phox2b Expression in Tumors of the Autonomic Nervous System

Daisuke Nonaka et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)

Article Oncology

Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome

Gabriel G. Malouf et al.

EUROPEAN JOURNAL OF CANCER (2013)

Article Pathology

GATA3 Immunohistochemical Expression in Salivary Gland Neoplasms

Lauren E. Schwartz et al.

HEAD & NECK PATHOLOGY (2013)

Article Pathology

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

Kristina Magnusson et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2011)